ABOUT™ Report: 78% of Health System Leaders Say Patient Leakage a Higher Priority After COVID-19 View more
BlueAllele Corporation Secures Second Patent from USPTO Strengthening the Company’s Position in Targeted Insertion and Gene Correction Technologies View more
Be The Match BioTherapies and Atara Biotherapeutics Announce Multi-Year Partnership Extension View more
